Suchergebnisse - "Weis, Nina"

PubPharm (8)

1

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study

enthalten in: PloS one | 2017

von Dalgard, O. | Weiland, O. | Noraberg, G. | +14

2

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection : a randomised study

enthalten in: Gut | 2015

von Hézode, C. | Hirschfield, G. | Ghesquiere, W. | +31

3

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection

enthalten in: Gastroenterology | 2015

von Dore, G. | Lawitz, E. | Hézode, C. | +24

4

Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses : lack of correlation to treatment outcome

enthalten in: PloS one | 2013

von Pedersen, J. | Jensen, T. | Carlsen, T. | +6

5

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C : a Danish nationwide cohort study

enthalten in: BMC infectious diseases | 2011

von Hansen, N. | Obel, N. | Christensen, P. | +17

6

Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C

enthalten in: European journal of gastroenterology & hepatology | 2011

von Andersen, E. | Moessner, B. | Christensen, P. | +4

7

High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment

enthalten in: Journal of virology | 2009

von Gonzalez, V. | Falconer, K. | Blom, K. | +6

8

Pegylated interferon-alpha for the treatment of chronic hepatitis C

enthalten in: Ugeskrift for laeger | 2003

von Weis, N. | Krarup, H. | Skinhøj, P.

1
[1]